Stock CTXR CITIUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Citius Pharmaceuticals, Inc.

Equities

CTXR

US17322U2078

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		Pre-market 07:03:21 am
0.6648 USD -9.25% Intraday chart for Citius Pharmaceuticals, Inc. 0.675 +1.53%
Apr. 26 Citius Pharmaceuticals Launches $15 Million Offering MT
Apr. 11 Citius Pharmaceuticals, Inc. Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. CTXR Stock
  4. Revisions Citius Pharmaceuticals, Inc.